Article
Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
Biochemical and biophysical research communications - 29 Jan 2022
Lupala Cecylia S, Ye Yongjin, Chen Hong, Su Xiao-Dong, Liu Haiguang
Abstract excerpt
The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to more than 270 million infections and 5.3 million of deaths worldwide. Several major variants of SARS-CoV-2 have emerged and posed challenges in controlling the pandemic. The recently occurred Omicron variant raised serious concerns about reducing the efficacy of vaccines and neutralization antibodies due to its vast mutations. We have modelled the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
